JBIO · Jade Biosciences, Inc. · Documents
$14.59
-0.32 (-2.15%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 10, 2026
Market Cap
$927.89M
Shares
63.60M
Volume · Oct 23
634.38K
Avg daily vol (3M)
903.02K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-03-30 | — | |
| 8-K | — | 2021-12-15 | — | |
| 8-K | — | 2021-11-15 | — | |
| 10-Q | — | 2021-11-15 | 2021-09-30 | |
| 8-K | — | 2021-08-16 | — | |
| 10-Q | — | 2021-08-16 | 2021-06-30 | |
| 8-K | — | 2021-08-12 | 2021-08-06 | |
| 8-K | — | 2021-07-19 | 2021-07-15 | |
| 8-K | — | 2021-07-02 | 2021-06-29 | |
| S-1/A | — | 2021-06-25 | — | |
| S-1/A | — | 2021-06-24 | — | |
| S-1/A | — | 2021-06-17 | — | |
| S-1 | — | 2021-06-09 | — |
Showing 101–113 of 113 filings
Key facts
CIK
1798749
CUSIP
008064206
13F (30d)
13 filings
13 filers
Visit website
Investor relations